SAC Capital Slashes Stake in Intercept Pharmaceuticals (ICPT) to Near 0%
Get Alerts ICPT Hot Sheet
Join SI Premium – FREE
In an amended 13G filing on Intercept Pharmaceuticals (NASDAQ: ICPT), Steven Cohen's hedge fund SAC Capital disclosed a 0.03%, or 6,123 share, stake in the company. This is down 99.55% from the 1,369,046 shares held at the end of the latest quarter.
For more notable holders of Intercept Pharmaceuticals stock click here. For more information on SAC Capital click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- PENN Entertainment (PENN) Climbs after Hedge Fund Greenlight Takes Stake
- HP Inc. (HPQ) Climbs Following Stake by Greenlight Capital
Create E-mail Alert Related Categories
13GsRelated Entities
SAC Capital, Steven A. Cohen, Hedge Funds, 13GSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!